Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

Low Molecular Weight Heparin Therapy

An Evaluation of Clinical Trials Evidence
Buch | Hardcover
488 Seiten
1999
Marcel Dekker Inc (Verlag)
978-0-8247-8213-9 (ISBN)
CHF 214,70 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Gathers the clinical studies. This book reviews the different biochemical properties, and assesses the therapeutic efficacy of low molecular weight heparins. It compares the benefits of LMWHs prophylaxis with the risk of hemorrhage; and more. It is for anesthesiologists, surgeons, primary care physicians, internists, cardiologists, and others.
Each section is followed with expert commentary and a critical evaluation of the studies under consideration!
This reference, unique in format, gathers the most relevant clinical studies, reviews the different biochemical properties, and assesses the therapeutic efficacy of low molecular weight heparins (LMWHs) from 1985 to the present.
Presents each study on two pages-the first describes the main parameters of the study, including experimental conditions, location, number of patients, medications, surgical procedures, and anesthesia type, and the second provides a table of results based on the study's data!
With contributions from 35 leading international physicians, Low Molecular Weight Heparin Therapy
recommends treatment practices based on levels of evidence attained in the studies

questions specific therapeutic practices when researchers fail to

provides systematic documentation of the various therapeutic indications of LMWHs

compares the benefits of LMWHs prophylaxis with the risk of hemorrhage

evaluates the ease of delivery of prophylactic therapy and treatment of thromboembolic disease

favors narrative review of each study over meta-analysis

and more!
Containing hundreds of tables, and scrupulously referenced to substantiate the critical appraisals, Low Molecular Weight Heparin Therapy is a single-volume reference ideal for anesthesiologists, surgeons, primary care physicians, internists, cardiologists, hematologists, pharmacologists, epidemiologists, and medical students in these disciplines.

Marketed Low Molecular Weight Heparins
Chemical and Biological Properties
Prophylaxis of Venous Thromboembolism
International Consensus Statement
Treatment of Venous Thromboembolism
Anti-Xa Activity Monitoring
Synoptic Tables
Prophylaxis and Treatment of Arterial Thrombosis
Low Molecular Weight Heparins in Pregnancy
Low Molecular Weight Heparins in Pediatrics
Low Molecular Weight Heparins and Osteoporosis
Low Molecular Weight Heparins and Induced Thrombocytopenia
Low Molecular Weight Heparins and Neutralization by Protamine
Low Molecular Weight Heparins and Meta-Analyses (References)
Conclusions and Beyond

Verlagsort New York
Sprache englisch
Maße 216 x 279 mm
Gewicht 1089 g
Themenwelt Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizin / Pharmazie Medizinische Fachgebiete Laboratoriumsmedizin
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Biologie Genetik / Molekularbiologie
ISBN-10 0-8247-8213-5 / 0824782135
ISBN-13 978-0-8247-8213-9 / 9780824782139
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Diagnostik und interventionelle Therapie | 2 Bände

von Raimund Erbel; Michael Haude; Philipp Kahlert; Björn Plicht …

Buch (2024)
Deutscher Ärzteverlag
CHF 489,95